Red signs and not severity of cirrhosis should determine non-selective β-blocker treatment in Child–Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use-Reference-Cited by-同舟云学术

Red signs and not severity of cirrhosis should determine non-selective β-blocker treatment in Child–Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use

Published:2016-03-02 Issue:7 Volume:65 Page:1228-1230
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Kalambokis Georgios N,Baltayiannis Gerasimos,Christou Leonidas,Christodoulou Dimitrios

Publisher

BMJ

Subject

Gastroenterology

Reference6 articles.

1. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients;Tripathi;Gut,2015

2. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension;De Franchis;J Hepatol,2015

3. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis;Garcia-Tsao;Hepatology,2007

4. The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease;Krag;Gut,2012

5. Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation;Leithead;Gut,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis;Annals of Medicine;2024-01-25

2. B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review;Biomedicines;2023-12-25

3. Non-selective Beta Blockers in Liver Cirrhosis;Pharmacotherapy for Liver Cirrhosis and Its Complications;2022

4. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis;World Journal of Hepatology;2021-07-27

5. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers;Clinics in Liver Disease;2021-05